BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37950538)

  • 1. Children's Oncology Group's 2023 blueprint for research: Surgery.
    Gow KW; Lautz TB; Malek MM; Cost NG; Newman EA; Dasgupta R; Christison-Lagay ER; Tiao GM; Davidoff AM;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30766. PubMed ID: 37950538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.
    Grupp SA; Dvorak CC; Nieder ML; Levine JE; Wall DA; Langholz B; Pulsipher MA;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1044-7. PubMed ID: 23255402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
    Kalapurakal JA; Wolden SL; Haas-Kogan D; Laack NN; Hua CH; Paulino AC; Hill-Kayser CE; Hoppe BS; Fitzgerald TJ;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30593. PubMed ID: 37486145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children's Oncology Group's 2013 blueprint for research: renal tumors.
    Dome JS; Fernandez CV; Mullen EA; Kalapurakal JA; Geller JI; Huff V; Gratias EJ; Dix DB; Ehrlich PF; Khanna G; Malogolowkin MH; Anderson JR; Naranjo A; Perlman EJ;
    Pediatr Blood Cancer; 2013 Jun; 60(6):994-1000. PubMed ID: 23255438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children's Oncology Group's 2013 blueprint for research: nursing discipline.
    Landier W; Leonard M; Ruccione KS
    Pediatr Blood Cancer; 2013 Jun; 60(6):1031-6. PubMed ID: 23255369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's Oncology Group's 2023 blueprint for research: Epidemiology.
    Lupo PJ; Marcotte EL; Scheurer ME; Poynter JN; Spector LG;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30566. PubMed ID: 37449937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children's Oncology Group's 2023 blueprint for research: Pharmacy.
    Ostrenga AR; Thackray J; McLearan HH; Mulieri KM; Bisaccia E; Militano O; Dupuis LL; Bernhardt MB;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30581. PubMed ID: 37460409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
    Bagatell R; DuBois SG; Naranjo A; Belle J; Goldsmith KC; Park JR; Irwin MS;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30572. PubMed ID: 37458162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.
    Freyer DR; Felgenhauer J; Perentesis J;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1055-8. PubMed ID: 23424167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children's Oncology Group's 2023 blueprint for research: Liver tumors.
    O'Neill AF; Meyers RL; Katzenstein HM; Geller JI; Tiao GM; López-Terrada D; Malogolowkin M;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30576. PubMed ID: 37495540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children's Oncology Group's 2013 blueprint for research: bone tumors.
    Gorlick R; Janeway K; Lessnick S; Randall RL; Marina N;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1009-15. PubMed ID: 23255238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children's Oncology Group's 2023 blueprint for research.
    Hawkins DS; Gore L
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30569. PubMed ID: 37433635
    [No Abstract]   [Full Text] [Related]  

  • 13. Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.
    Bhuta R; Shah R; Gell JJ; Poynter JN; Bagrodia A; Dicken BJ; Pashankar F; Frazier AL; Shaikh F
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30562. PubMed ID: 37449938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children's Oncology Group's 2023 blueprint for research: Renal tumors.
    Geller JI; Hong AL; Vallance KL; Evageliou N; Aldrink JH; Cost NG; Treece AL; Renfro LA; Mullen EA;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30586. PubMed ID: 37477907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and following common pediatric malignancies: MRI versus CT versus functional imaging.
    Voss SD
    Pediatr Radiol; 2018 Aug; 48(9):1324-1336. PubMed ID: 30078040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children's Oncology Group's 2013 blueprint for research: radiation oncology.
    Merchant TE; Hodgson D; Laack NN; Wolden S; Indelicato DJ; Kalapurakal JA;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1037-43. PubMed ID: 23255526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children's Oncology Group's 2013 blueprint for research: rare tumors.
    Rodriguez-Galindo C; Krailo M; Frazier L; Chintagumpala M; Amatruda J; Katzenstein H; Malogolowkin M; Spector L; Pashankar F; Meyers R; Tomlinson G;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1016-21. PubMed ID: 23255219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children's Oncology Group's 2023 blueprint for research: Behavioral science.
    Embry L; Bingen K; Conklin HM; Hardy S; Jacola LM; Marchak JG; Paltin I; Pelletier W; Devine KA
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30557. PubMed ID: 37430416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children's Oncology Group's 2023 blueprint for research: Rare tumors.
    Schultz KAP; Chintagumpala M; Piao J; Chen KS; Gartrell R; Christison-Lagay E; Berry JL; Shah R; Laetsch TW;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30574. PubMed ID: 37458616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.
    Esbenshade AJ; Sung L; Brackett J; Dupuis LL; Fisher BT; Grimes A; Miller TP; Ullrich NJ; Dvorak CC;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30568. PubMed ID: 37430431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.